Scarica l'app Stockscreener
13.47
0.45%
0.06
Dopo l'orario di chiusura:
13.64
0.17
+1.26%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BHVN Giù?
Forum
Previsione
Precedente Chiudi:
$13.41
Aprire:
$13.66
Volume 24 ore:
2.04M
Relative Volume:
0.99
Capitalizzazione di mercato:
$1.38B
Reddito:
-
Utile/perdita netta:
$-804.34M
Rapporto P/E:
-1.4315
EPS:
-9.41
Flusso di cassa netto:
$-531.06M
1 W Prestazione:
-11.61%
1M Prestazione:
-3.30%
6M Prestazione:
-68.02%
1 anno Prestazione:
-63.57%
Intervallo 1D:
$13.21
$13.80
Intervallo di 1 settimana:
$12.83
$15.29
Portata 52W:
$12.79
$55.70
Biohaven Ltd Stock (BHVN) Company Profile
Nome
Biohaven Ltd
Settore
Industria
Telefono
203-404-0410
Indirizzo
215 CHURCH STREET, NEW HAVEN, CT
Confronta BHVN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
13.47 | 1.37B | 0 | -804.34M | -531.06M | -9.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Biohaven Ltd Stock (BHVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-19 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-09-16 | Iniziato | Jefferies | Buy |
| 2024-09-04 | Iniziato | Bernstein | Outperform |
| 2024-07-24 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-16 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-02-06 | Iniziato | UBS | Buy |
| 2023-12-22 | Iniziato | H.C. Wainwright | Buy |
| 2023-12-08 | Iniziato | Robert W. Baird | Outperform |
| 2023-01-24 | Iniziato | SVB Securities | Outperform |
| 2023-01-04 | Iniziato | JP Morgan | Overweight |
| 2022-12-02 | Iniziato | BTIG Research | Buy |
| 2022-10-26 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2022-10-12 | Iniziato | Piper Sandler | Overweight |
| 2022-08-19 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-08-08 | Downgrade | Wedbush | Outperform → Neutral |
| 2022-05-11 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-19 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-08-10 | Downgrade | UBS | Buy → Neutral |
| 2021-08-03 | Reiterato | Canaccord Genuity | Buy |
| 2021-03-11 | Iniziato | UBS | Buy |
| 2020-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-17 | Iniziato | Cowen | Outperform |
| 2020-02-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-02-06 | Iniziato | Mizuho | Buy |
| 2019-11-22 | Iniziato | Wedbush | Outperform |
| 2019-06-25 | Reiterato | Canaccord Genuity | Buy |
| 2019-05-06 | Iniziato | Goldman | Buy |
| 2019-04-09 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-03-04 | Reiterato | Needham | Buy |
| 2018-07-03 | Reiterato | Needham | Buy |
| 2018-07-02 | Reiterato | Needham | Buy |
| 2018-04-05 | Downgrade | Barclays | Overweight → Equal Weight |
| 2018-02-22 | Reiterato | Canaccord Genuity | Buy |
| 2017-12-15 | Iniziato | Canaccord Genuity | Buy |
| 2017-10-03 | Reiterato | Needham | Buy |
Mostra tutto
Biohaven Ltd Borsa (BHVN) Ultime notizie
Can Biohaven Ltd. reach all time highs this yearRisk Adjusted Portfolio Ideas - thegnnews.com
Biohaven price target lowered to $30 from $54 at H.C. Wainwright - MSN
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven - GlobeNewswire
Biohaven price target lowered to $49 from $50 at BofA - MSN
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. LawsuitBHVN - Morningstar
Biohaven Ltd: Navigating Market Fluctuations with a 1.37B Market Cap - investchronicle.com
Biohaven Pharmaceutical stock price target lowered to $30 at H.C. Wainwright - Investing.com India
Biohaven Pharmaceutical stock price target lowered to $30 at H.C. Wainwright By Investing.com - Investing.com South Africa
Biohaven Ltd. Breaks Losing Streak — Is the Trend ReversingEarly Breakout Entry Point Notifications Sent - 선데이타임즈
Biohaven Ltd. Sued for Securities Law Violations – - GlobeNewswire
Bragar Eagel & Squire, P.C. Urges Investors in XPLR - GlobeNewswire
Bragar Eagel & Squire, P.C. Urges Investors in XPLR Infrastructure, Centene, Biohaven, or Capricor to Inquire About Their Rights in Class Action Lawsuits - GlobeNewswire Inc.
BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Lawsuit Alert: Investors who lost money with shares of Biohaven - openPR.com
Biohaven Ltd. (BHVN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Biohaven’s Strategic Advances and Promising Data Drive Buy Rating - TipRanks
Pomerantz Law Firm Announces the Filing of a Class Action Against Biohaven Ltd. and Certain OfficersBHVN - PR Newswire
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Biohaven Ltd.(BHVN) Shareholders - PR Newswire
Biohaven reports second quarter 2025 financial results - MarketScreener
Biohaven reports higher than expected R&D expenses in Q2 By Investing.com - Investing.com South Africa
Biohaven reports higher than expected R&D expenses in Q2 - Investing.com India
Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments - PR Newswire
Levi & Korsinsky Notifies Biohaven Ltd. (BHVN) InvestorsLead Plaintiff Deadline on September 12, 2025 - ACCESS Newswire
BHVN Investors Have Opportunity to Lead Biohaven Ltd. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
BHVN Investors Have Opportunity to Lead Biohaven Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Visual analytics tools that track Biohaven Ltd. performancePredictive Short-Term Market Reversal Alerts - Newser
Candlestick signals on Biohaven Ltd. stock todayAI Screener for Daily Stock Forecast - Newser
BHVN ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Biohaven Ltd.September 12, 2025 Deadline - ACCESS Newswire
Biohaven Ltd. stock prediction for this weekPrice Action Trading with Volume Confirmation - Newser
Published on: 2025-08-09 04:28:36 - Newser
Biohaven Ltd. (NYSE:BHVN) Receives Average Rating of “Buy” from Brokerages - Defense World
Can Biohaven Ltd. recover in the next quarterFree Earnings Play Trade Plan With Alerts - Newser
Applying big data sentiment scoring on Biohaven Ltd.Investment Timeline and ROI Summary Report - Newser
Real time alert setup for Biohaven Ltd. performanceFree Breakout Entry Signal Confirmation Tool - Newser
Class Action Filed Against Biohaven Ltd. (BHVN) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biohaven Ltd.(BHVN) Shareholders - GlobeNewswire
Shareholders that lost money on Biohaven Ltd.(BHVN) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - Morningstar
Exit strategy if you’re trapped in Biohaven Ltd.High Probability Trade Plan with Indicators - Newser
How to interpret RSI for Biohaven Ltd. stockFree Daily Volume Spike Trading Signals - Newser
Deadline Alert: Biohaven Ltd. (BHVN) Investors Who Lost - GlobeNewswire
BHVN LAWSUIT ALERT: Levi & Korsinsky Notifies Biohaven Ltd. InvestorsLead Plaintiff Deadline September 12, 2025 - ACCESS Newswire
Biohaven Ltd. Sued for Securities Law ViolationsContact The Gross Law Firm Before September 12, 2025 to Discuss Your RightsBHVN - Barchart.com
Biohaven (BHVN) to Release Quarterly Earnings on Thursday - Defense World
Biohaven Ltd. (NYSE:BHVN) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank - Defense World
Does Biohaven Ltd. show high probability of reboundAI Powered Stock Trend Prediction Model - Newser
Investors in Biohaven Ltd. (BHVN): Protect Your RightsContact Levi & Korsinsky Before September 12, 2025 - ACCESS Newswire
BHVN INVESTORS: Kirby McInerney LLP Reminds Biohaven Ltd. - GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Biohaven - GlobeNewswire
Biohaven Ltd. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – BHVN - Morningstar
Securities Lawsuit Alert: Biohaven Ltd. (BHVN) InvestorsContact Levi & Korsinsky Before September 12, 2025 - ACCESS Newswire
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH - Defense World
Biohaven Ltd Azioni (BHVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):